Pengitoxin | CAS# 7242-04-8 | Penta-acetylated gitoxin

MedKoo Cat#: 412377 | Name: Pengitoxin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pengitoxin is penta-acetylated gitoxin.

Chemical Structure

Pengitoxin

CAS#7242-04-8

Theoretical Analysis

MedKoo Cat#: 412377

Name: Pengitoxin

CAS#: 7242-04-8

Chemical Formula: C51H74O19

Exact Mass: 990.4824

Molecular Weight: 991.13

Elemental Analysis: C, 61.80; H, 7.53; O, 30.67

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Pengitoxin; Cordoval; Pentagit; EINECS 230-645-5

IUPAC/Chemical Name

(2R,3R,4S,6S)-6-(((2R,3R,4S,6S)-4-acetoxy-6-(((2R,3R,4S,6R)-4-acetoxy-6-(((3S,5R,8R,9S,10S,13R,14S,16S,17R)-16-acetoxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl)oxy)-2-methyltetrahydro-2H-pyran-3,4-diyl diacetate

InChi Key

JDYLJSDIEBHXPO-ALNZGLKXSA-N

InChi Code

InChI=1S/C51H74O19/c1-24-46(67-31(8)56)37(63-27(4)52)20-43(61-24)69-48-26(3)62-44(21-39(48)65-29(6)54)70-47-25(2)60-42(19-38(47)64-28(5)53)68-34-13-15-49(9)33(18-34)11-12-36-35(49)14-16-50(10)45(32-17-41(57)59-23-32)40(66-30(7)55)22-51(36,50)58/h17,24-26,33-40,42-48,58H,11-16,18-23H2,1-10H3/t24-,25-,26-,33-,34+,35+,36-,37+,38+,39+,40+,42+,43+,44+,45+,46-,47-,48-,49+,50-,51+/m1/s1

SMILES Code

C[C@H]1O[C@@H](O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@@]5([C@@H](C6=CC(OC6)=O)[C@@H](OC(C)=O)C[C@]45O)C)C)C[C@@H]([C@@H]1O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)OC(C)=O)OC(C)=O)OC(C)=O)OC(C)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 991.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Haustein KO, Alken RG, Lach HJ, Becker U, Rietbrock N. On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl- gitoxin. Eur J Clin Pharmacol. 1983;25(3):369-73. doi: 10.1007/BF01037950. PMID: 6628525. 2: Haustein KO, Wesser M. Pharmacokinetics of pengitoxin and its therapeutic efficacy in congestive heart failure. Int J Clin Pharmacol Ther Toxicol. 1988 Jan;26(1):8-15. PMID: 3403092. 3: Haustein KO, Oltmanns G, Rietbrock N, Alken RG. Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin. J Cardiovasc Pharmacol. 1982 Jul-Aug;4(4):536-41. doi: 10.1097/00005344-198207000-00003. PMID: 6181326. 4: Haustein KO. On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations. J Pharmacokinet Biopharm. 1986 Aug;14(4):357-64. doi: 10.1007/BF01059196. PMID: 3772737. 5: Haustein KO, Hentschel H. Dose-dependent shortening of systolic time intervals after intake of pengitoxin. Int J Clin Pharmacol Res. 1987;7(1):19-25. PMID: 3583485. 6: Emmrich R, Wagner J, Axthelm EH. Die Bindungskapazitäten der Serumproteine für Herzglykoside (speziell für Pengitoxin) [The binding capacity of serum proteins for cardiac glycosides (especially for pengitoxin)]. Munch Med Wochenschr. 1969 Feb 21;111(8):401-4. German. PMID: 5818954. 7: Kozák P. Untersuchungen über die Herzwirkung eines neuen, fünffach azetylierten Gitoxins (Pengitoxin [Cardiac effect of a new penta-acetylated gitoxin (pengitoxin)]. Ther Ggw. 1974 Mar;113(3):430-2 passim. German. PMID: 4818043. 8: Haustein KO, Wesser M. Kliniko-farmakologicheskoe i klinicheskoe issledovanie pengitoksina [Clinico-pharmacological and clinical evaluation of pengitoxin]. Farmakol Toksikol. 1982 May-Jun;45(3):67-8. Russian. PMID: 7095131. 9: Haustein KO. Measurement of plasma glycoside level following pengitoxin administration. Eur J Clin Pharmacol. 1978 Jul 30;13(5):389-91. doi: 10.1007/BF00644614. PMID: 668799. 10: Haustein KO, Schmidt C. Differences in color discrimination between three cardioactive glycosides. Int J Clin Pharmacol Ther Toxicol. 1988 Oct;26(10):517-20. PMID: 3235219.